汉姆斯健康

最新新闻

• 公司公告
  Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
  SEC · 2026/6/18
• 评级变动
  BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Cuts Target Price to $30
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  A Quick Look at Today's Ratings for Hims & Hers Health(HIMS.US), With a Forecast Between $32 to $42
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  J.P. Morgan Assigns Hims & Hers Stock a 'Hold' Rating. What's Behind the Cautious Stance?
  TipRanks · 2026/9/12
• 公司公告
  Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
  SEC · 2026/3/18
• BofA Securities Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/9/25
• Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 公司公告
  Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Director Cosgrove Delos M.
  SEC · 2026/6/16
• 评级变动
  CCORF Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Maintains Target Price $40
  \u5e02\u573a\u8d44\u8baf · 2026/7/24
• KeyBanc Maintains Hims & Hers Health(HIMS.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 评级变动
  Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $33
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Citi Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Maintains Target Price $35
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• J.P. Morgan Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 公司公告
  8-K: Hims & Hers Health | 8-K: Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
  SEC · 2026/5/12
• 评级变动
  Truist Financial Maintains Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $32
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 公司公告
  Hims & Hers Health | 4: Statement of changes in beneficial ownership of securities-Officer Autor Deborah M.
  SEC · 2026/6/16
• 评级变动
  BTIG Maintains Hims & Hers Health(HIMS.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  Barclays Maintains Hims & Hers Health(HIMS.US) With Buy Rating, Cuts Target Price to $35
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• Jefferies Initiates Hims & Hers Health(HIMS.US) With Hold Rating, Announces Target Price $31
  \u5e02\u573a\u8d44\u8baf · 2026/9/3

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。